Document:

Exhibit 10.30

 

Second
Amendment to Amended and Restated Credit Agreement

  

This
Second Amendment to Amended and Restated Credit Agreement (herein, this “Amendment”) is entered into as of
October 12, 2019, among Global Medical REIT L.P., a Delaware limited partnership
(the “Borrower”), Global Medical REIT Inc., a Maryland corporation
(the “Parent” or “Global Medical REIT”), as a Guarantor, the other Guarantors party hereto,
the Lenders party hereto, and BMO Harris Bank N.A., as Administrative Agent (in
such capacity, the “Administrative Agent”).

 

Preliminary
Statements

 

A.        Borrower,
Parent, the other Guarantors party thereto, the Lenders party thereto, and the Administrative Agent have heretofore entered into
that certain Amended and Restated Credit Agreement, dated as of August 7, 2018, as amended by the First Amendment to Amended and
Restated Credit Agreement, dated as of September 30, 2019 (such Credit Agreement being referred to herein as the “Credit
Agreement”). All capitalized terms used herein without definition shall have the same meanings herein as such terms
have in the Credit Agreement, as amended by this Amendment.

 

B.        Due
to a scrivener’s error in Section 2.1(a) of the Credit Agreement, Borrower, Administrative Agent and the Lenders have agreed
to enter into this Amendment to adjust the fees provided for therein.

 

C.        This
Amendment shall constitute a Loan Document and these Preliminary Statements shall be construed as part of this Amendment.

 

Now,
Therefore, for good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:

 

Section 1.        Amendment
to Credit Agreement.

 

Subject
to the satisfaction of the conditions precedent set forth in Section 3 below, Section 2.1(a) of the Credit Agreement is hereby
amended and restated to read as follows:

 

         (a)        Revolving
Credit Commitment Fee. The Borrower shall pay to the Administrative Agent for the ratable account of the Lenders in accordance
with their Revolver Percentages a commitment fee on the average daily Unused Revolving Credit Commitments at a rate per annum
equal to (x) 0.20% if the average daily Unused Revolving Credit Commitments are less than or equal to 50% of the Revolving Credit
Commitments then in effect and (y) 0.25% if the average daily Unused Revolving Credit Commitments are greater than 50% of the
Revolving Credit Commitments then in effect (in each case, computed on the basis of a year of 360 days and the actual number of
days elapsed) and determined based on the average daily Unused Revolving Credit Commitments during such previous quarter. Such
commitment fee shall be payable quarterly in arrears on the last day of each March, June, September, and December in each year
(commencing September 30, 2018) and on the Termination Date, unless the Revolving Credit Commitments are terminated in whole on
an earlier date, in which event the commitment fee for the period to the date of such termination in whole shall be calculated
and paid on the date of such termination. Any such commitment fee for the first quarter ending after the Closing Date shall be
prorated according to the number of days this Agreement was in effect during such quarter.

 

     

     

    

 

Section
2.        Reaffirmation of Guaranties.

 

Each
Guarantor hereby (i) acknowledges and consents to the terms of this Amendment and the Credit Agreement as amended by this
Amendment, (ii) confirms that its Guaranty in favor of the Administrative Agent, for the benefit of the Lenders, and all
of its obligations thereunder, as amended, remain in full force and effect and (iii) reaffirms all of the terms, provisions,
agreements and covenants contained in its Guaranty. Each Guarantor agrees that its consent to any further amendments or modifications
to the Credit Agreement and other Loan Documents shall not be required solely as a result of this acknowledgment and consent having
been obtained, except to the extent, if any, required by any Guaranty.

 

Section 3.        Conditions
Precedent.

 

The
effectiveness of this Amendment is subject to the satisfaction of all of the following conditions precedent:

 

         3.1.        The
Administrative Agent shall have received this Amendment duly executed by the Borrower, each Guarantor, and the Lenders.

 

         3.2.        Legal
matters incident to the execution and delivery of this Amendment shall be reasonably satisfactory to the Administrative Agent
and its counsel.

 

Section 4.        Representations.

 

In
order to induce the Administrative Agent and the Lenders to execute and deliver this Amendment, the Borrower and each other Guarantor
hereby represents to the Administrative Agent and the Lenders that (a) after giving effect to this Amendment, the representations
and warranties set forth in Section 6 of the Credit Agreement, as amended by this Amendment, are and shall be and remain
true and correct in all material respects as of the date hereof (or, if any such representation and warranty is expressly stated
to have been made as of a specific date, as of such specific date) and (b) no Default or Event of Default has occurred and
is continuing under the Credit Agreement or shall result after giving effect to this Amendment.

 

Section 5.        Miscellaneous.

 

5.1.        Except
as specifically amended herein, the Credit Agreement shall continue in full force and effect in accordance with its original terms.
Reference to this specific Amendment need not be made in the Credit Agreement, the Notes, the other Loan Documents, or any other
instrument or document executed in connection therewith, or in any certificate, letter or communication issued or made pursuant
to or with respect to the Credit Agreement, any reference in any of such items to the Credit Agreement being sufficient to refer
to the Credit Agreement as amended hereby.

 

    	 	-2-	 

     

    

 

5.2.        The
Borrower agrees to pay on demand all reasonable costs and out-of-pocket expenses of or incurred by the Administrative Agent in
connection with the negotiation, preparation, execution and delivery of this Amendment, including the reasonable fees and out-of-pocket
expenses of counsel for the Administrative Agent.

 

5.3.        This
Amendment may be executed in any number of counterparts, and by the different parties on different counterpart signature pages,
all of which taken together shall constitute one and the same agreement. Any of the parties hereto may execute this Amendment
by signing any such counterpart and each of such counterparts shall for all purposes be deemed to be an original. Delivery of
an executed counterpart of a signature page of this Amendment by facsimile or in electronic (e.g., “pdf” or “tif”)
format shall be effective as delivery of a manually executed counterpart of this Amendment. This
Amendment, and the rights and duties of the parties hereto, shall be construed and determined in accordance with the laws of the
State of New York (including Section 5-1401 and Section 5-1402 of the General Obligations law of the State of New York)
without regard to conflicts of law principles that would require application of the laws of another jurisdiction.

 

[Signature
Pages Follow]

  

    	 	-3-	 

     

    

 

This
Second Amendment to Amended and Restated Credit Agreement is entered into as of the date and year first above written.

 

	 	Borrower:	 
	 	 	 
	 	Global
    Medical REIT L.P.	 
	 	 	 
	 	By: 	Global
Medical REIT GP, LLC,

        a
Delaware limited liability company,

        its
        General Partner

         
	 
	 	 	By:	Global
Medical REIT Inc.,

        a Maryland
Corporation,

        its
        Sole Member

         
	 
	 	 	 	 	 
	 	 	By:	/s/ Jamie
    Barber	 
	 	 	Name:	Jamie Barber	 
	 	 	Date:	Corporate Secretary and General Counsel	 

 

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

 

	 	Guarantors:	 
	 	 	 	 	 
	 	GLOBAL MEDICAL REIT INC.	 
	 	 	 	 	 
	 	 	 	 	 
	 	By	 	/s/ Jamie
    Barber	 
	 	Name:	Jamie
    Barber	 
	 	Title:	Corporate Secretary and General Counsel	 

 

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

  

	 	GMR ALBERTVILLE, LLC
	 	GMR ALTOONA, LLC
	 	GMR AMARILLO, LLC
	 	GMR ASHEVILLE, LLC
	 	GMR AURORA, LLC
	 	GMR AUSTIN, LLC
	 	GMR BANNOCKBURN, LLC
	 	GMR BOUNTIFUL, LLC
	 	GMR BROCKPORT, LLC
	 	GMR CAPE CORAL, LLC
	 	GMR CARSON CITY, LLC
	 	GMR CHANDLER DOBSON, LLC
	 	GMR CHANDLER PECOS I, LLC
	 	GMR CHANDLER PECOS II, LLC
	 	GMR CHANDLER VAL VISTA I, LLC
	 	GMR CINCINNATI BEECHMONT, LLC
	 	GMR CLERMONT, LLC
	 	GMR CORONA, LLC
	 	GMR DERBY, LLC
	 	GMR EAST DALLAS HOSPITAL, LLC
	 	GMR EAST DALLAS LAND, LLC
	 	GMR EAST ORANGE, LLC
	 	GMR ELLIJAY, LLC
	 	GMR FLOWER MOUND, LLC
	 	GMR FORT WORTH, LLC
	 	GMR FREMONT, LLC
	 	GMR GAINESVILLE, LLC
	 	GMR GERMANTOWN, LLC
	 	GMR GREAT BEND, LLC
	 	GMR LANSING JOLLY 3390, LLC
	 	GMR LANSING JOLLY 3400, LLC
	 	GMR LANSING JOLLY PATIENT, LLC
	 	GMR LAS CRUCES, LLC
	 	GMR LAS VEGAS, LLC
	 	GMR LEE’S SUMMIT, LLC
	 	GMR LEWISBURG, LLC
	 	GMR LIVONIA, LLC
	 	GMR LUBBOCK, LLC
	 	GMR MCALLEN, LLC

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

  

     

     

    

 

	 	GMR MECHANICSBURG, LLC
	 	GMR MELBOURNE PINE, LLC
	 	GMR MESA, LLC
	 	GMR MOLINE, LLC
	 	GMR OKLAHOMA CITY, LLC
	 	GMR OKLAHOMA NORTHWEST, LLC
	 	GMR OMAHA, LLC
	 	GMR ORLANDO, LLC
	 	GMR PRESCOTT, LLC
	 	GMR READING, LLC
	 	GMR SAINT GEORGE, LLC
	 	GMR SAN MARCOS, LLC
	 	GMR SANDUSKY, LLC
	 	GMR SHERMAN, LLC
	 	GMR SOUTH BEND, LLC
	 	GMR SOUTHERN IL, LLC
	 	GMR SOUTHERN IL SHILOH 1191, LLC
	 	GMR SOUTHERN IL SHILOH 1197, LLC
	 	GMR SOUTHERN IL CARBONDALE, LLC
	 	GMR SURPRISE, LLC
	 	GMR VERNON, LLC
	 	GMR VERNON KEYNOTE, LLC
	 	GMR WATERTOWN, LLC
	 	GMR WYOMISSING, LLC
	 	GMR ZACHARY, LLC

 

	 	By:  	
        Global
Medical REIT L.P.,

        a Delaware limited
partnership,

        its Sole Member

         
	 
	 	 	By: 	
        Global
Medical REIT GP, LLC,

        a Delaware limited
liability company,

        its General Partner

         
	 
	 	 	 	By:	
        Global
Medical REIT Inc.,

        a Maryland Corporation,

        its Sole Member

         
	 
	 	 	 	 	 	 
	 	 	 	By:	/s/ Jamie
    Barber	 
	 	 	 	Name:	Jamie
    Barber	 
	 	 	 	Title:	Corporate Secretary and General Counsel	 

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

  

	 	Administrative Agent:	 
	 	 	 	 	 
	 	BMO Harris Bank N.A., as L/C Issuer and as

 Administrative Agent
	 	 	 	 	 
	 	 	 	 	 
	 	By:	/s/ Michael Kauffman	 
	 	 	Name:	Michael Kauffman	 
	 	 	Title:	Managing Director	 
	 	 	 	 	 
	 	 	 	 	 
	 	Lenders:	 
	 	 	 	 	 
	 	BMO Harris Bank N.A., as a Lender	 
	 	 	 	 	 
	 	 	 	 	 
	 	By:	/s/ Michael Kauffman	 
	 	 	Name:	Michael Kauffman	 
	 	 	Title:	Managing Director	 

 

     

     

    

 

	 	Citizens Bank,
N.A.	 
	 	 	 
	 	 	 
	 	By	/s/ Frank Kaplan	 
	 	 	Name	 Frank Kaplan	 
	 	 	Title	Vice President	 

  

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

 

	 	SunTrust Bank	 
	 	 	 
	 	 	 
	 	By	/s/ Anton Brykalin	 
	 	 	Name	 Anton Brykalin	 
	 	 	Title	Vice President	 

  

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

 

	 	The Huntington National Bank	 
	 	 	 
	 	 	 
	 	By	/s/ Eva McQuillen	 
	 	 	Name	Eva McQuillen	 
	 	 	Title	Vice President	 

 

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

  

	 	Wells Fargo Bank, National Association	 
	 	 	 
	 	 	 
	 	By	/s/ Darin Mullis	 
	 	 	Name	 Darin Mullis	 
	 	 	Title	Managing Director	 

 

  

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

  

	 	Comerica Bank	 
	 	 	 
	 	 	 
	 	By	/s/ Casey L. Stevenson	 
	 	 	Name	Casey L. Stevenson	 
	 	 	Title	Vice President	 
	 	 	 	 	 

  

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

  

     

     

    

 

	 	KeyBank National Association	 
	 	 	 
	 	 	 
	 	By	/s/ Gregory W. Lane	 
	 	 	Name	Gregory W. Lane	 
	 	 	Title	Senior Vice President	 

  

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]

 

     

     

    

  

	 	Franklin Synergy Bank	 
	 	 	 	 	 
	 	 	 	 	 
	 	By	/s/ Lisa Fletcher	 
	 	 	Name	 Lisa Fletcher	 
	 	 	Title	Senior Vice President	 

 

 

[Signature
Page to Second Amendment to Amended and Restated Credit Agreement (Global Medical REIT L.P.)]crvs_Ex4_5

		
			Exhibit 4.5
		

		
			 
		

		
			DESCRIPTION OF REGISTRANT’S SECURITIES
		

		
			REGISTERED PURSUANT TO SECTION 12 OF THE
		

		
			SECURITIES EXCHANGE ACT OF 1934
		

		
			 
		

		
			As of December 31, 2019, Corvus Pharmaceuticals, Inc. (“Corvus”) had common stock, $0.001 par value per share, registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and listed on The Nasdaq Global Market under the trading symbol “CRVS.”
		

		
			 
		

		
			DESCRIPTION OF CAPITAL STOCK
		

		
			 
		

		
			The following summary describes our capital stock and the material provisions of our amended and restated certificate of incorporation, our amended and restated bylaws, the amended and restated investors’ rights agreement to which we and certain of our stockholders are parties and of the Delaware General Corporation Law. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete description, you should refer to our amended and restated certificate of incorporation, amended and restated bylaws and amended and restated investor rights agreement, copies of which are incorporated by reference as Exhibits 3.1, 3.2 and 4.3, respectively, to our Annual Report on Form 10-K.
		

		
			 
		

		
			General
		

		
			 
		

		
			Our authorized capital stock consists of 300,000,000 shares of common stock, $0.0001 par value per share, and 10,000,000 shares of preferred stock, $0.0001 par value per share. As of December 31, 2019, there were outstanding:
		

		
			 
		

			
	
			
				 ·
			

			
	
			
			27,953,233 shares of our common stock held by approximately 25 stockholders of record;

		
			 
		

			
	
			
				 ·
			

			
	
			
			5,643,410 shares of our common stock issuable upon exercise of outstanding stock options; and

		
			 
		

			
	
			
				 ·
			

			
	
			
			1,458,000 shares of our common stock issuable upon the exercise of outstanding warrants.

		
			 
		

		
			The actual number of stockholders is greater than the number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.
		

		
			 
		

		
			The following description of our capital stock and provisions of our amended and restated certificate of incorporation and amended and restated bylaws are summaries of material terms and provisions and are qualified by reference to our amended and restated certificate of incorporation and amended and restated bylaws, copies of which have been filed with the SEC and are incorporated by reference as exhibits to the registration statement of which this prospectus is a part.
		

		
			 
		

		
			Common Stock
		

		
			 
		

		
			Voting Rights
		

		
			 
		

		
			Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors. In addition, the affirmative vote of holders of 66 2/3% of the voting power of all of the then outstanding voting stock is required to take certain actions, including amending certain provisions of our amended and restated certificate of incorporation, such as the provisions relating to amending our amended and restated bylaws, the classified board of directors and director liability.
		

		
			 
		

		
			Dividends
		

		
			 
		

		
			Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds.
		

		
			 
		

		
			
		

		
			

		 

		

		
			 
		

		
			Liquidation
		

		
			 
		

		
			In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock.
		

		
			 
		

		
			Rights and Preferences
		

		
			 
		

		
			Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock that we may designate in the future.
		

		
			 
		

		
			Fully Paid and Nonassessable
		

		
			 
		

		
			All of our outstanding shares of common stock are fully paid and nonassessable.
		

		
			 
		

		
			Preferred Stock
		

		
			 
		

		
			Our board of directors has the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of our common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company or other corporate action. As of January 31, 2020, no shares of preferred stock were outstanding, and we have no present plan to issue any shares of preferred stock.
		

		
			 
		

		
			Registration Rights
		

		
			 
		

		
			Under our amended and restated investors’ rights agreement, as of December 31, 2019, the holders of approximately 10 million shares of common stock, or their transferees, have the right to require us to register their shares under the Securities Act so that those shares may be publicly resold, and the holders of approximately 10 million shares of common stock, or their transferees, have the right to include their shares in any registration statement we file, in each case as described below.
		

		
			 
		

		
			Demand Registration Rights
		

		
			 
		

		
			Based on the number of shares outstanding as of December 31, 2019, the holders of approximately 10 million shares of our common stock, or their transferees, are entitled to certain demand registration rights. The holders of at least 30% of these shares can, on not more than two occasions, request that we register all or a portion of their shares if the aggregate price to the public of the shares offered is at least $5.0 million (after deductions of underwriters’ discounts and expenses related to the issuance).
		

		
			 
		

		
			Piggyback Registration Rights
		

		
			 
		

		
			Based on the number of shares outstanding as of December 31, 2019, in the event that we determine to register any of our securities under the Securities Act of 1933, as amended (the “Securities Act”) (subject to certain exceptions), either for our own account or for the account of other security holders, the holders of approximately 10 million shares of our common stock, or their transferees, are entitled to certain “piggyback” registration rights allowing the holders to include their shares in such registration, subject to certain marketing and other limitations.
		

		
			
		

		
			

		 

		

		
			 
		

		
			As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to a registration related to employee benefit plans, the offer and sale of debt securities, or corporate reorganizations or certain other transactions, the holders of these shares are entitled to notice of the registration and have the right, subject to limitations that the underwriters may impose on the number of shares included in the registration, to include their shares in the registration. In an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to exclude or limit the number of shares such holders may include.
		

		
			 
		

		
			Form S-3 Registration Rights
		

		
			 
		

		
			Based on the number of shares outstanding as of December 31, 2019, the holders of approximately 10 million shares of our common stock, or their transferees, are entitled to certain Form S-3 registration rights. The holders of any of these shares can make a written request that we register their shares on Form S-3 if we are eligible to file a registration statement on Form S-3 and if the aggregate price to the public of the shares offered is at least $2.0 million (after deductions of underwriters’ discounts and expenses related to the issuance). These stockholders may make an unlimited number of requests for registration on Form S-3, but in no event shall we be required to file more than two registrations on Form S-3 in any given twelve-month period.
		

		
			 
		

		
			Expenses of Registration
		

		
			 
		

		
			We will pay the registration expenses of the holders of the shares registered pursuant to the demand, piggyback and Form S-3 registration rights described above, including the expenses in an amount not to exceed $35,000 of one special counsel for the selling holders.
		

		
			 
		

		
			Expiration of Registration Rights
		

		
			 
		

		
			The demand, piggyback and Form S-3 registration rights described above will expire, with respect to any particular stockholder, upon the earlier of four years after the consummation of our initial public offering in March 2016 or when that stockholder can sell all of its shares under Rule 144 of the Securities Act during any 90-day period (and without the requirement for the Company to be in compliance with the current public information required under Section c(1) of Rule 144 of the Securities Act).
		

		
			 
		

		
			Anti-Takeover Effects of Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware Law
		

		
			 
		

		
			Certain provisions of Delaware law and our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that could make the following transactions more difficult: acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares.
		

		
			 
		

		
			These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.
		

		
			 
		

		
			Delaware Anti-Takeover Statute
		

		
			 
		

		
			We are subject to Section 203 of the Delaware General Corporation Law, which prohibits persons deemed “interested stockholders” from engaging in a “business combination” with a publicly-held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15%
		

		
			
		

		
			

		 

		

		
			 
		

		
			or more of a corporation’s voting stock. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, such as discouraging takeover attempts that might result in a premium over the market price of our common stock.
		

		
			 
		

		
			Undesignated Preferred Stock
		

		
			 
		

		
			The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of our company.
		

		
			 
		

		
			Special Stockholder Meetings
		

		
			 
		

		
			Our amended and restated bylaws provide that a special meeting of stockholders may be called at any time by our board of directors, but such special meetings may not be called by the stockholders or any other person or persons.
		

		
			 
		

		
			Requirements for Advance Notification of Stockholder Nominations and Proposals
		

		
			 
		

		
			Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors.
		

		
			 
		

		
			Stockholder Action by Written Consent
		

		
			 
		

		
			Our amended and restated certificate of incorporation and our amended and restated bylaws preclude stockholder action by written consent without a meeting.
		

		
			 
		

		
			Classified Board; Election and Removal of Directors; Filling Vacancies
		

		
			 
		

		
			Our board of directors is divided into three classes. The directors in each class serve for a three-year term, with one class being elected each year by our stockholders, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding will be able to elect all of our directors. Our amended and restated certificate of incorporation provides for the removal of any of our directors only for cause and requires a stockholder vote by the holders of at least a 66 2/3% of the voting power of the then outstanding voting stock. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of the board, may only be filled by the affirmative vote of a majority of the directors then in office unless the board of directors determines that such vacancies shall be filled by the stockholders. This system of electing and removing directors and filling vacancies may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors.
		

		
			 
		

		
			Choice of Forum
		

		
			 
		

		
			Our amended and restated certificate of incorporation and our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the exclusive forum for: any derivative action or proceeding brought on our behalf; any action asserting a claim of breach of fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. Although our amended and restated certificate of incorporation and amended and restated bylaws contain the choice of forum provision described above, it is possible that a court could find that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable.
		

		
			 
		

		
			
		

		
			

		 

		

		
			 
		

		
			Amendment of Charter Provisions
		

		
			 
		

		
			The amendment of any of the above provisions in our amended and restated certificate of incorporation, except for the provision making it possible for our board of directors to issue undesignated preferred stock, or the amendment of any provision in our bylaws (other than by action of the board of directors), requires approval by a stockholder vote by the holders of at least a 66 2/3% of the voting power of the then outstanding voting stock.
		

		
			 
		

		
			The provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation and our amended and restated bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.
		

		
			 
		

		
			Limitations of Liability and Indemnification Matters
		

		
			 
		

		
			Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for:
		

		
			 
		

			
	
			
				 ·
			

			
	
			
			any breach of the director’s duty of loyalty to us or our stockholders;

			
	
			
				 ·
			

			
	
			
			any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

			
	
			
				 ·
			

			
	
			
			unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or

			
	
			
				 ·
			

			
	
			
			any transaction from which the director derived an improper personal benefit.

		
			Each of our amended and restated certificate of incorporation and amended and restated bylaws provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated bylaws also obligate us to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors’ and officers’ liability insurance.
		

		
			 
		

		
			The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders. Further, a stockholder’s investment may be adversely affected to the extent that we pay the costs of settlement and damages.
		

		
			 
		

		
			Transfer Agent and Registrar
		

		
			 
		

		
			The transfer agent and registrar for our common stock is Computershare, Inc. The transfer agent and registrar’s address is 480 Washington Boulevard, 29th Floor, Jersey City, New Jersey 07130.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]